Researchers at the University of Nottingham, UK, have announced their discovery of a previously undetected layer in the cornea, the clear window at the front of the human eye.
News
A new implant that allows patients suffering from advanced age-related macular degeneration (AMD) to improve their general vision and regain independence is now being implanted in the UK.
The foldable glued-IOL technique provides satisfactory and safe visual outcomes, claims a paper in the latest issue of the Journal of Cataract and refractive Surgery.
Repeated pars plana vitrectomy, with internal limiting membrane peeling and gas tamponade, is a safe and effective treatment technique for persistent macular holes, states an investigation in the Journal of Retinal and Vitreous Diseases.
With-the-rule astigmatism (WTA) reduces reading parameters and near visual acuity (NVA) compared with against-the-rule astigmatism (ATR) and no astigmatism, according to a recent paper.
Cocaine-assisted epithelial debridement is a simple and inexpensive treatment method for symptomatic anterior basement membrane dystrophy (ABMD) patients, reveals the latest study in the journal Cornea.
Long-term positive outcomes of a minimally invasive retrobulbar episcleral brachytherapy device (SalutarisMD, Salutaris Medical Devices, London, UK) show promise for treating wet age-related macular degeneration (wAMD), according to data presented at the RCO congress.
JETREA (ThromboGenics, Leuven, Belgium) has launched in Denmark and Sweden with roll out of the drug to follow shortly in Finland and Norway. These launches will be performed by ThromboGenics partner, Alcon.
Primary endpoint results, demonstrating the non-inferiority of the BIOTRONIK Orsiro hybrid drug-eluting stent compared to Abbott?s XIENCE PRIME, from the BIOFLOW-II clinical study have been revealed at the EuroPCR congress in Paris.
The National Institute for Health and Care Excellence (NICE) has announced that Eylea (aflibercept, Bayer HealthCare, Leverkusen, Germany) should be recommended for the treatment of patients with wet age related macular degeneration (wAMD).
Comparative study results support use of once-daily treatment, but both satisfactory
A round-up of the latest ophthalmic products
An exciting new option in combination with cataract surgery
Positioning the ExPRESS shunt in the glaucoma surgeon's practice
Procedure has ability to lower IOP, preserve vision similar to trabeculectomy and tube shunts
Moderately cohesive ophthalmic viscosurgical devices offer desired performance traits
Ability to observe details of deep retinal structures noninvasively and clearly
Using an anatomically accurate OCT-derived neuroretinal rim parameter
Investigating tolerability of a diagnostic device in healthy and glaucomatous patients
The rationale for optimizing the ocular surface in glaucoma patients
Intracanalicular device providing durable IOP reduction as standalone procedure
Evaluation of a new system
Imaging with autofluorescence and SD-OCT can help
LASIK may pose a great risk of post-op dry eye
The AREDS2 report has recently been published with important implications for those afflicted with early stage AMD...
Both inferior oblique (IO) recession in the primary position and in contralateral gaze are largely self-grading and there were no significant differences at three months postoperatively, states an investigation.
The variable duty cycle (DC) control on dual pneumatic ultra high-speed 23G cutters has an important effect on the vitreous flow but this is reduced at high cut rates as a result of convergence, reveals a paper in Retina.
The 2.75 mm three-plane clear corneal incision (CCI) created with a femtosecond (FS) laser produces comparable outcomes to single-plane angled manual incision for anterior and posterior corneal topography, claims a new study.
Digital devices may be used as a visual rehabilitation technique for low-vision AMD patients, according to a paper featured in the journal Eye.
Advertisement
Advertisement
